A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)

Yazar
Zeuzem, Stefan
Bock, Thomas
Dienes, Hans P.
Bozkaya, Hakan
Degertekin, Ha
Gurel, Sa.
Zachou, Kalliopi
Manns, Michael P.
Yurdaydin, Cihan
Wedemeyer, Heiner
Dalekos, George
Erhardt, Alexander
Cakaloglu, Ya
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/119224
Koleksiyonlar